All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
|
|
|
|
|
|
| MTEM / Molecular Templates, Inc.
|
|
|
|
|
|
|
|
| YMTX / Yumanity Therapeutics Inc
|
|
|
|
|
|
|
|
| CLSD / Clearside Biomedical, Inc.
|
|
|
|
|
|
|
|
| PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AVXS / AveXis, Inc.
|
|
|
|
|
|
|
|
| REPH / Societal CDMO Inc
|
|
|
|
|
|
|
|
| SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NERV / Minerva Neurosciences, Inc.
|
|
|
|
|
|
|
|
| ALDR / Alder BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| 451731103 / Ignyta, Inc.
|
|
|
|
|
|
|
|
| CLRBW / Cellectar Biosciences, Inc. Warrants expiring 8/20/2019
|
|
|
|
|
|
|
|
| RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
| FWP / Forward Pharma A/S - ADR
|
|
|
|
|
|
|
|
| RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| OVID / Ovid Therapeutics Inc.
|
|
|
|
|
|
|
|
| CRVS / Corvus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| AGRX / Agile Therapeutics, Inc.
|
|
|
|
|
|
|
|
| US7170711045 / Pfenex Inc.
|
|
|
|
|
|
|
|
| GTHX / G1 Therapeutics, Inc.
|
|
|
|
|
|
|
|
| FLGT / Fulgent Genetics, Inc.
|
|
|
|
|
|
|
|
| XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
| IMDZ / Immune Design Corp.
|
|
|
|
|
|
|
|
| US62857M1053 / MyoKardia, Inc.
|
|
|
|
|
|
|
|
| ONSIZ / Oncobiologics, Inc. Series B Warrant Expiring 5/18
|
|
|
|
|
|
|
|
| ONSIW / Oncobiologics, Inc. Series A Warrant Expiring 2/18/2018
|
|
|
|
|
|
|
|
| BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
| BOLD / Boundless Bio, Inc.
|
|
|
|
|
|
|
|
| IL0011177958 / Intec Pharma Ltd
|
|
|
|
|
|
|
|
| TRIL / Trillium Therapeutics Inc
|
|
|
|
|
|
|
|
| ZYME / Zymeworks Inc.
|
|
|
|
|
|
|
|
| AAAP / Advanced Accelerator Applications S.A
|
|
|
|
|
|
|
|
| NVRO / Nevro Corp.
|
|
|
|
|
|
|
|
| US64052L1061 / Neos Therapeutics, Inc.
|
|
|
|
|
|
|
|
| EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
| ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
| JUNO / Juno Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
| CFRX / ContraFect Corp
|
|
|
|
|
|
|
|
| ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GEMP / Gemphire Therapeutics Inc.
|
|
|
|
|
|
|
|
| SYNH / Syneos Health Inc - Class A
|
|
|
|
|
|
|
|
| SYRS / Syros Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| QTNT / Quotient Ltd
|
|
|
|
|
|
|
|
| DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
| JNCE / Jounce Therapeutics Inc
|
|
|
|
|
|
|
|
| GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
|
|
|
|
|
|
|
|
| DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
| XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
| OTLK / Outlook Therapeutics, Inc.
|
|
|
|
|
|
|
|
| HTGM / HTG Molecular Diagnostics Inc
|
|
|
|
|
|
|
|
| ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| 0PP / Portola Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| 0PP / Portola Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| CBPO / China Biologic Products Holdings Inc
|
|
|
|
|
|
|
|
| MYOV / Myovant Sciences Ltd
|
|
|
|
|
|
|
|
| TGXSF / Tigenix Sa
|
|
|
|
|
|
|
|
| CRIS / Curis, Inc.
|
|
|
|
|
|
|
|
| SRNE / Sorrento Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TBPH / Theravance Biopharma, Inc.
|
|
|
|
|
|
|
|
| IVTY / Invuity, Inc.
|
|
|
|
|
|
|
|
| COLL / Collegium Pharmaceutical, Inc.
|
|
|
|
|
|
|
|
| AVEO / AVEO Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| / Array BioPharma, Inc.
|
|
|
|
|
|
|
|
| GLYC / GlycoMimetics, Inc.
|
|
|
|
|
|
|
|
| AGEN / Agenus Inc.
|
|
|
|
|
|
|
|
| MRSN / Mersana Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VIRX / Viracta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ZYNE / Zynerba Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
| APTO / Aptose Biosciences Inc.
|
|
|
|
|
|
|
|
| SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
| CLRB / Cellectar Biosciences, Inc.
|
|
|
|
|
|
|
|
| RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
| EGRX / Eagle Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| OMER / Omeros Corporation
|
|
|
|
|
|
|
|
| ABEO / Abeona Therapeutics Inc.
|
|
|
|
|
|
|
|
| NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
| LPCN / Lipocine Inc.
|
|
|
|
|
|
|
|
| CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
